-
Michigan third most preferred destination in Midwest for life science investment
biospectrumasia
September 12, 2017
Michigan third most preferred destination in Midwest for life science investment Michigan ranked behind Ohio, with US $293.7 million in 55 deals, and regional leader Minnesota, with US $337 million in 59 investments.
-
Vaccine market expected to grow at a CAGR of 7.5% by 2022
pharmaasia
August 29, 2017
The vaccine market is forecast to reach US$49.27 billion by 2022 at a CAGR of 7.5% from US$34.30 billion in 2017.
-
Positive outlook for biotech M&A and funding, says report
pharmatimes
August 11, 2017
A report examining the European venture landscape for health and biotech firms over the first half of 2017 has found that there is a continuing positive environment for venture funding and M&A in the sector.
-
Japanese telecom giant injects $1.1bn into Swiss biotech in largest-ever investment of its kind
pharmafile
August 11, 2017
In possibly the biggest single biotech investment ever made, Swiss biotech firm Roivant has received a $1.1 billion cash injection thanks to an investment from Japanese telecom giant SoftBank.
-
Transfer technology expert expands US presence following multi-million-pound investment
cphi-online
July 20, 2017
Investment follows demand for the company's AseptiSafe and PharmaSafe product ranges, which transfer APIs in small- and large-scale pharmaceutical manufacturing environments.
-
BASF plans significant investment in ibuprofen capacities in Germany and North America
cphi-online
June 30, 2017
New world-scale ibuprofen production plant in Ludwigshafen; additional capacity expansion of ibuprofen plant in Bishop, Texas.
-
$15 million investment by Tekni- Plex
biospectrumasia
June 19, 2017
It represents the single largest recent investment by Tekni-Plex and reflects the growing needs of the Asia-Pacific pharmaceutical and medical device market.
-
The Big Era for Investment of “RNAi Drugs” from the Perspective of Two Newly Approved Drugs by FDA
en-cphi.cn
June 16, 2017
FDA approved the Exondys 51 (eteplirsen) of Sarepta Therapeutics on September 19, 2016 for treating exon 51 skipping Duchenne muscular dystrophy (DMD).
-
Tekni-Plex announces $15 million investment
pharmaasia
June 14, 2017
Tekni-Plex announces $15 million investment in new China manufacturing facility.
-
Govt approves Rs 1500 cr investment to develop bio pharmaceuticals
financialexpress
May 18, 2017
The primary objective of the programme is to forge an industry-academia collaborative mission for accelerating discovery research to early development for biopharmaceuticals
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
